Clinical Trial Update: VTE Incidence After Rivaroxaban + Aspirin or SAPT After Lower-limb Revascularization [Phase 4]

View source ↗

Summary

Phase 4 trial assessing the incidence of venous thromboembolism after rivaroxaban plus aspirin versus single antiplatelet therapy following lower-limb revascula…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Carotid Artery Stenosis
• Peripheral Arterial Disease
• Peripheral Vascular Disease
• Venous Thromboembolism

Drugs mentioned

• Aspirin (Aspirin)
• Rivaroxaban (rivaroxaban)

Snippet

Sponsor: Science Valley Research Institute | Conditions: Peripheral Arterial Disease, Venous Thormboembolism | Phase 4 | Status: RECRUITING